FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to pharmaceutical industry and is intended for the prevention and treatment of fungal diseases caused by Escherichia coli, Candida sp., Aspergillus niger, Saccharomyces cerevisiae. Capsule consists of a shell and a composition enclosed in it in the form of an oil suspension, including unrefined black cumin oil (29.7-44.7 wt.%), magnesium caprylate (5.8-8.8 wt.%), essential bark cinnamon oil (0.6-0.9 wt.%), CO2-extract of cloves (0.48-0.72 wt.%), edible tea tree essential oil (0.17-0.26 wt.%), essential garlic oil (0.12-0.18 wt.%) and filler. Shell weight of one capsule is 324-396 mg. The capsule shell consists of a suture soft gelatin shell containing gelatin, a humectant, and an enteric shell, containing Collicut MAE 100P, a humectant, anti-caking agent, thickener and colorants. Shell weights are equal.
EFFECT: provides increased capsule antimicrobial and antifungal activity due to the use of the claimed composition.
7 cl, 4 tbl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID BALM AND A METHOD OF ITS PREPARATION | 2022 |
|
RU2805656C1 |
| DIGITAL MICROBIOLOGY | 2017 |
|
RU2772844C2 |
| STREPTOMYCES SPECIES STRAIN RECOVERED FROM BAIKAL ENDEMIC AMPHIPODS - PRODUCER OF ACTIOPHENOL ANTIBIOTIC | 2018 |
|
RU2704862C1 |
| POLYPEPTIDES HAVING ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | 2006 |
|
RU2512525C2 |
| RECOMBINANT DEFENSIN EXPRESSION IN FILAMENTOUS FUNGI | 2006 |
|
RU2404990C2 |
| ANTIMICROBIAL POLYPEPTIDES FROM PSEUDOPLECTANIA NIGRELLA | 2002 |
|
RU2336278C2 |
| ANTIMICROBIAL PEPTIDE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | 2011 |
|
RU2611173C2 |
| 2-MERCAPTOBENZOYL HYDRAZONES OF MONOSE, HAVING ANTIMICROBIAL AND ANTIFUNGAL ACTIVITY | 2010 |
|
RU2454423C1 |
| POLYPEPTIDES WITH ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES CODING THEM | 2005 |
|
RU2393224C2 |
| ANTIMICROBIAL MICELLES FOR USAGE IN FOOD PRODUCTS | 2007 |
|
RU2469623C2 |
